Australia's online magazine for entrepreneurs & SMEs

Back to 'Lessons from Top Entrepreneurs' Articles

SEND TO A FRIEND PRINT

Cup of re-charge juice

Tuesday, 8 January 2008

Last Updated: Thursday, 22 May 2008

 

 Watch Nabi Saleh from Gloria Jean’s Coffees talk about building the franchise chain.

When Nabi Saleh (right) and Peter Irvine brought the US coffee concept to Australia in 1998 they had to make big changes to suit Australians, adding seating and snacks to the menu. The model was finessed over 18 months to become what it is today. 

In 2005 Saleh and Irvine bought the international rights to Gloria Jean's and focused on exporting. Today, if you sit down to a Gloria Jean’s coffee in any country in the world, the beans will have come from the same warehouse in Sydney. There are now more than 400 stores in Australia and over 750 outlets in more than 50 countries. Export accounts for about 35% of revenue.  

 

 

 

 

You can now watch past episodes of Your Business Success on the NEW Sky News Business Channel, channel 602 on Saturdays at 9pm and Sundays 3.30pm & 9pm!

Advertisement

More: Lessons from Top Entrepreneurs

View > Must like dogs

Tuesday, 26 August 2008 The big blue "Rover" grooming trailer is the distinctive feature of all Hydrodog franchisees. See founder Martin Rose talk about the gestation and growth of the business.

View > What's your beef?

Tuesday, 19 August 2008 Watch the video of Harry Lawson, owner of beef stud Lawson Angus, share his secrets of success. By JACQUI WALKER.

View > Growing concern

Tuesday, 12 August 2008 A life-changing event has been turned into a successful enterprise by Mark Millis, as he explains.

View > Learning how to let go

Tuesday, 5 August 2008 As a business grows, there comes a time when the founder cannot control everything and has to step back and let other take control of aspects of the business. Top entrepreneurs give their insights.

View > Sleeper hit

Tuesday, 29 July 2008 Sleep-disordered breathing problems are a big problem, and one that ResMed has been successfully treating. With estimates that the disorder is only 7% diagnosed, the potential market for ResMed is huge.